Keyword: Racing Medication and Testing Consortium

  • Survey: Drug Testing System Has Serious Flaws

    Research commissioned by The Jockey Club shows that, though the Thoroughbred industry has made progress in the area of uniform medication and testing standards, a state-by-state approach is at best problematic.

  • Arkansas Adopts Uniform Medication Rules

    The Arkansas Racing Commission approved the entire program Sept. 11. Once implemented, Arkansas will become the sixth state to fully administer the Racing Medication and Testing Consortium's National Uniform Medication rules.

  • Kentucky to Tackle Drug Compounder Concerns

    In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.

  • Horsemen's Groups Circle Wagons on Lasix

    In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.

  • West Virginia Racing Commission Meeting

    WV Hires New Lab; Purse Money Still in Limbo

    The West Virginia Racing Commission Aug. 1 hired Truesdail Laboratories in California to handle its equine drug testing and will ask the lab to test about 40 "cloudy samples" from a three-week period in July.

  • Alex Waldrop

    Waldrop: Uniform Drug Rules Must Be Adopted

    Racing jurisdictions have made progress on equine medication reform but states and their regulatory agencies must commit to move quickly and in unison, said Alex Waldrop, president of the NTRA and chairman of the RMTC.

  • Groups Step Up Call for Model Drug Rules

    Racing industry organizations have greatly stepped up their call for swift adoption of national model rules on medication and drug testing in the wake of probes into allegations of mistreatment and over-medication of horses.

  • RMTC Amends Therapeutic Medications List

    The Racing Medication and Testing Consortium board of directors took several actions March 17 intended to further the process toward the nationwide adoption of uniform medication rules, penalties, and testing.

  • Kentucky Horsemen Prepped on New Drug Rules

    Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.

  • New Standards May Be Imposed on NY Stewards

    New York racing regulators raised the prospects of imposing new transparency standards on stewards, including possibly publicly releasing videos that are used by officials in decisions affecting the outcome of a race.

  • Booklet on MD Medication Guidelines Released

    A booklet put together by several individuals at the forefront of equine medication reform has been prepared for Maryland, which will enact the Mid-Atlantic Uniform Medication and Drug-Testing Program Jan. 1, 2014.

  • Multi-Breed Drug Uniformity No Easy Task

    Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.

  • RMTC Position Papers Uphold Thresholds

    A pair of position papers released by the Racing Medication and Testing Consortium find no physiologic difference in various racing breeds to justify changes to its regulatory thresholds for clenbuterol and corticosteroids.

  • NTRA Shows Support for Industry Reforms

    The NTRA is submitting a letter to the Energy and Commerce Subcommittee on Commerce, Manufacturing, and Trade outlining progress in the national reform effort to enhance the safety and integrity of racing.

  • Texas Compounder Draws Industry Scrutiny

    Regulators and racing leaders are taking a close look at facilities such as the Weatherford Compounding Pharmacy in Texas, which offers products with names such as Equine Growth Hormone, Game Changer, and Tourniquet.

  • Medication, Testing Reforms Gain Support

    The National Thoroughbred Racing Association has reported that the effort to adopt uniform national reforms addressing changes to medication regulation, enforcement, and laboratory testing continues to gain support.

  • USTA Creates Medication Advisory Committee

    The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.

  • Foreman: Drug Uniformity Won't Be Sidetracked

    A major proponent for national uniform medication rules said Sept. 26 the move by the United States Trotting Association to drop out of the Racing Medication and Testing Consortium won't derail the effort.

  • USTA Says No to Model Rules, Leaves RMTC

    The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.

  • RMTC Recommends Prohibition of Stanozolol

    The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.

  • Confidentiality in Research Called Necessary

    An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.

  • RMTC Board Approves Model Rule on Penalties

    The Racing Medication and Testing Consortium said July 19 its board of directors has approved a model rule on multiple violation penalties and forwarded the suggested change to racing commissioners for consideration.

  • Scientists Question Clenbuterol Regulations

    Scientific and regulatory advisers to the National Horsemen's Benevolent and Protective Association July 13 expressed concerns over the proposed withdrawal time and testing level for the bronchodilator clenbuterol.

  • RMTC Accredits First Two Laboratories

    The University of California-Davis Kenneth L. Maddy Laboratory and HFL Sport Science in Lexington became the first two fully accredited laboratories under the RMTC Laboratory Accreditation program June 11.

  • Stanley Bergstein Award

    Writing Award Prize Benefits RMTC

    The $25,000 prize intended for three New York Times writers will instead benefit drug testing programs. The newspaper's editorial ethics policy prohibits the writers from accepting the award.